Joseph E. Knapp, Ph.D. is Professor Emeritus of Pharmaceutical Sciences at the School of Pharmacy, University of Pittsburgh. He received his B.S. in Pharmacy (with Distinction in Pharmacy) in 1963 from the Ohio State University, College of Pharmacy and earned the M.S. (1965) and Ph.D. (1969) from the same institution. He was Assistant Professor of Pharmacognosy at Rutgers University (1969-1970) and joined the University of Pittsburgh as Assistant Professor of Pharmacognosy in December 1970. He was promoted to Associate Professor (with tenure) in 1973 and Professor in 1986. On his retirement from active service in 2005, he was granted emeritus status.
Dr. Knapp has been active in several professional societies and held elected and appointed positions in them. He was elected a Fellow of the American Association of Pharmaceutical Scientists (AAPS) and is an American Foundation for Pharmaceutical Education (AFPE) Fellow. He was honored with the Jack L. Beal Postbaccalaureate Award in 1996 from his alma mater, the Ohio State University College of Pharmacy. Dr. Knapp has served on various review and advisory panels for the National Institutes of Health (NIH), United States Department of Agriculture (USDA) and the Department of State.
Prior to his retirement, Dr. Knapp taught extensively in the professional degree program. His teaching focus was in the Pharmacotherapy of Infectious Disease, Immunology and Pharmaceutical Biotechnology. He was selected by the students as Teacher of the Year in 1984 and 2002 and Faculty Member of the Year in 1989, 2001 and 2005. He was also active in the M.S. and Ph.D. programs, serving as major advisor for 10 Ph.D. students and on the dissertation committees of numerous others in the School of Pharmacy and other departments.
Dr. Knapp's research interests were in the isolation and identification of naturally occurring substances, including alkaloids and fungal metabolites and in the development of model systems for the study of mammalian metabolism. He developed the use of chlorine dioxide gas as a sterilant for medical devices and isolators and other enclosed spaces. This research resulted in five US and several foreign patents. Recently, his recent research involved the use of gene transfer methods to develop a mouse model to assess the expression of human cytochrome P450 (CYP2C9) genes.
Dr. Knapp has served on the United States Pharmacopeia (USP) Committee of Revision (1990-2000) as a member of the Microbiology Subcommittee, chairing that committee from 1995 to 2000. He also served on the USP Division of Standards Development Executive Committee and the Ad- Hoc Committee on the Scope of the USP. He was elected to the Council of Experts of the USP for the 2000-05 term and served as the chair of the Analytical Microbiology Committee of Experts. He also served as a member of the Executive Committee of the General Policies and Requirements Division as well as several other USP committees. In recognition of his years of service he was honored with election as an honorary member of the United States Pharmacopeial Convention.